Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02677922 |
|---|---|
| Brief Title: | A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy |
| First Submitted : | February 5, 2016 |
| First Submitted that Met QC Criteria : | February 5, 2016 |
| First Posted : | February 9, 2016 (Estimate) |
| Results First Submitted : | September 2, 2022 |
| Results First Submitted that Met QC Criteria : | October 28, 2022 |
| Results First Posted : | November 22, 2022 |
| Last Update Submitted that Met QC Criteria : | January 23, 2024 |
| Last Update Posted : | January 25, 2024 |